359 related articles for article (PubMed ID: 1660359)
1. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
[TBL] [Abstract][Full Text] [Related]
2. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
[TBL] [Abstract][Full Text] [Related]
3. EMD 53998 acts as Ca(2+)-sensitizer and phosphodiesterase III-inhibitor in human myocardium.
Uhlmann R; Schwinger RH; Lues I; Erdmann E
Basic Res Cardiol; 1995; 90(5):365-71. PubMed ID: 8585857
[TBL] [Abstract][Full Text] [Related]
4. Relation of positive inotropic and chronotropic effects of pimobendan, UD-CG 212 Cl, milrinone and other phosphodiesterase inhibitors to phosphodiesterase III inhibition in guinea-pig heart.
Brunkhorst D; v der Leyen H; Meyer W; Nigbur R; Schmidt-Schumacher C; Scholz H
Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):575-83. PubMed ID: 2549430
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.
Fujino K; Sperelakis N; Solaro RJ
Circ Res; 1988 Nov; 63(5):911-22. PubMed ID: 2846200
[TBL] [Abstract][Full Text] [Related]
6. The novel cardiotonic agent EMD 53 998 is a potent "calcium sensitizer".
Beier N; Harting J; Jonas R; Klockow M; Lues I; Haeusler G
J Cardiovasc Pharmacol; 1991 Jul; 18(1):17-27. PubMed ID: 1719287
[TBL] [Abstract][Full Text] [Related]
7. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
Berger C; Meyer W; Scholz H; Starbatty J
Arzneimittelforschung; 1985; 35(11):1668-73. PubMed ID: 2418846
[TBL] [Abstract][Full Text] [Related]
8. Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts.
Bethke T; Eschenhagen T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Rosswag S
Arzneimittelforschung; 1992 Apr; 42(4):437-45. PubMed ID: 1386515
[TBL] [Abstract][Full Text] [Related]
9. The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.
Lues I; Beier N; Jonas R; Klockow M; Haeusler G
J Cardiovasc Pharmacol; 1993 Jun; 21(6):883-92. PubMed ID: 7687712
[TBL] [Abstract][Full Text] [Related]
10. The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments.
Solaro RJ; Fujino K; Sperelakis N
J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S7-12. PubMed ID: 2478795
[TBL] [Abstract][Full Text] [Related]
11. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
Schwinger RH; Böhm M; Müller-Ehmsen J; Uhlmann R; Schmidt U; Stäblein A; Uberfuhr P; Kreuzer E; Reichart B; Eissner HJ
Circulation; 1993 Nov; 88(5 Pt 1):2267-76. PubMed ID: 8222121
[TBL] [Abstract][Full Text] [Related]
12. Effects of isomazole on force of contraction and phosphodiesterase isoenzymes I-IV in nonfailing and failing human hearts.
Bethke T; Klimkiewicz A; Kohl C; von der Leyen H; Mehl H; Mende U; Meyer W; Neumann J; Schmitz W; Scholz H
J Cardiovasc Pharmacol; 1991 Sep; 18(3):386-97. PubMed ID: 1720839
[TBL] [Abstract][Full Text] [Related]
13. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of the effectiveness of milrinone to increase force of contraction by stimulation of cardiac beta-adrenoceptors in the failing human heart.
Böhm M; Diet F; Kemkes B; Erdmann E
Klin Wochenschr; 1988 Oct; 66(19):957-62. PubMed ID: 2846949
[TBL] [Abstract][Full Text] [Related]
15. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.
Böhm M; Beuckelmann D; Brown L; Feiler G; Lorenz B; Näbauer M; Kemkes B; Erdmann E
Eur Heart J; 1988 Aug; 9(8):844-52. PubMed ID: 2460351
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E
J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological actions of the pimobendan metabolite, UD-CG 212 Cl, in guinea pig myocardium.
Westfall MV; Wahler GM; Fujino K; Solaro RJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):58-63. PubMed ID: 1346167
[TBL] [Abstract][Full Text] [Related]
18. Selective inhibition of cAMP phosphodiesterase III activity by the cardiotonic agent saterinone in guinea pig myocardium.
Brunkhorst D; von der Leyen H; Meyer W; Schmidt-Schumacher C; Scholz H
Arzneimittelforschung; 1988 Sep; 38(9):1293-8. PubMed ID: 2852013
[TBL] [Abstract][Full Text] [Related]
19. Reduced alpha 1- and beta 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure.
Steinfath M; Danielsen W; von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Reich T; Schmitz W; Scholz H
Br J Pharmacol; 1992 Feb; 105(2):463-9. PubMed ID: 1348446
[TBL] [Abstract][Full Text] [Related]
20. Different mechanisms involved in the positive inotropic effects of benzimidazole derivative UD-CG 115 BS (pimobendan) and its demethylated metabolite UD-CG 212 Cl in canine ventricular myocardium.
Endoh M; Shibasaki T; Satoh H; Norota I; Ishihata A
J Cardiovasc Pharmacol; 1991 Mar; 17(3):365-75. PubMed ID: 1711596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
